Paul M Vespa1, DaiWai M Olson2, Sayona John3, Kyle S Hobbs4, Kapil Gururangan5, Kun Nie6, Masoom J Desai7, Matthew Markert8, Josef Parvizi8, Thomas P Bleck7, Lawrence J Hirsch9, M Brandon Westover10. 1. Departments of Neurology and Neurosurgery, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA. 2. Department of Neurology, University of Texas Southwestern Medical School, Dallas, TX. 3. Department of Neurology, Rush University Medical Center, Chicago, IL. 4. Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC. 5. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY. 6. Clindata Insight Inc, Moraga, CA. 7. Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL. 8. Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA. 9. Department of Neurology, Yale University School of Medicine, New Haven, CT. 10. Department of Neurology, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVES: To measure the diagnostic accuracy, timeliness, and ease of use of Ceribell rapid response electroencephalography. We assessed physicians' diagnostic assessments and treatment plans before and after rapid response electroencephalography assessment. Primary outcomes were changes in physicians' diagnostic and therapeutic decision making and their confidence in these decisions based on the use of the rapid response electroencephalography system. Secondary outcomes were time to electroencephalography, setup time, ease of use, and quality of electroencephalography data. DESIGN: Prospective multicenter nonrandomized observational study. SETTING: ICUs in five academic hospitals in the United States. SUBJECTS: Patients with encephalopathy suspected of having nonconvulsive seizures and physicians evaluating these patients. INTERVENTIONS: Physician bedside assessment of sonified electroencephalography (30 s from each hemisphere) and visual electroencephalography (60 s) using rapid response electroencephalography. MEASUREMENTS AND MAIN RESULTS: Physicians (29 fellows or residents, eight attending neurologists) evaluated 181 ICU patients; complete clinical and electroencephalography data were available in 164 patients (average 58.6 ± 18.7 yr old, 45% females). Relying on rapid response electroencephalography information at the bedside improved the sensitivity (95% CI) of physicians' seizure diagnosis from 77.8% (40.0%, 97.2%) to 100% (66.4%, 100%) and the specificity (95% CI) of their diagnosis from 63.9% (55.8%, 71.4%) to 89% (83.0%, 93.5%). Physicians' confidence in their own diagnosis and treatment plan were also improved. Time to electroencephalography (median [interquartile range]) was 5 minutes (4-10 min) with rapid response electroencephalography while the conventional electroencephalography was delayed by several hours (median [interquartile range] delay = 239 minutes [134-471 min] [p < 0.0001 using Wilcoxon signed rank test]). The device was rated as easy to use (mean ± SD: 4.7 ± 0.6 [1 = difficult, 5 = easy]) and was without serious adverse effects. CONCLUSIONS: Rapid response electroencephalography enabled timely and more accurate assessment of patients in the critical care setting. The use of rapid response electroencephalography may be clinically beneficial in the assessment of patients with high suspicion for nonconvulsive seizures and status epilepticus.
OBJECTIVES: To measure the diagnostic accuracy, timeliness, and ease of use of Ceribell rapid response electroencephalography. We assessed physicians' diagnostic assessments and treatment plans before and after rapid response electroencephalography assessment. Primary outcomes were changes in physicians' diagnostic and therapeutic decision making and their confidence in these decisions based on the use of the rapid response electroencephalography system. Secondary outcomes were time to electroencephalography, setup time, ease of use, and quality of electroencephalography data. DESIGN: Prospective multicenter nonrandomized observational study. SETTING: ICUs in five academic hospitals in the United States. SUBJECTS: Patients with encephalopathy suspected of having nonconvulsive seizures and physicians evaluating these patients. INTERVENTIONS: Physician bedside assessment of sonified electroencephalography (30 s from each hemisphere) and visual electroencephalography (60 s) using rapid response electroencephalography. MEASUREMENTS AND MAIN RESULTS: Physicians (29 fellows or residents, eight attending neurologists) evaluated 181 ICU patients; complete clinical and electroencephalography data were available in 164 patients (average 58.6 ± 18.7 yr old, 45% females). Relying on rapid response electroencephalography information at the bedside improved the sensitivity (95% CI) of physicians' seizure diagnosis from 77.8% (40.0%, 97.2%) to 100% (66.4%, 100%) and the specificity (95% CI) of their diagnosis from 63.9% (55.8%, 71.4%) to 89% (83.0%, 93.5%). Physicians' confidence in their own diagnosis and treatment plan were also improved. Time to electroencephalography (median [interquartile range]) was 5 minutes (4-10 min) with rapid response electroencephalography while the conventional electroencephalography was delayed by several hours (median [interquartile range] delay = 239 minutes [134-471 min] [p < 0.0001 using Wilcoxon signed rank test]). The device was rated as easy to use (mean ± SD: 4.7 ± 0.6 [1 = difficult, 5 = easy]) and was without serious adverse effects. CONCLUSIONS: Rapid response electroencephalography enabled timely and more accurate assessment of patients in the critical care setting. The use of rapid response electroencephalography may be clinically beneficial in the assessment of patients with high suspicion for nonconvulsive seizures and status epilepticus.
Authors: Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: R J DeLorenzo; E J Waterhouse; A R Towne; J G Boggs; D Ko; G A DeLorenzo; A Brown; L Garnett Journal: Epilepsia Date: 1998-08 Impact factor: 5.864
Authors: J Claassen; N Jetté; F Chum; R Green; M Schmidt; H Choi; J Jirsch; J A Frontera; E Sander Connolly; R G Emerson; S A Mayer; L J Hirsch Journal: Neurology Date: 2007-09-25 Impact factor: 9.910
Authors: Gian Marco De Marchis; Deborah Pugin; Emma Meyers; Angela Velasquez; Sureerat Suwatcharangkoon; Soojin Park; M Cristina Falo; Sachin Agarwal; Stephan Mayer; J Michael Schmidt; E Sander Connolly; Jan Claassen Journal: Neurology Date: 2015-12-23 Impact factor: 9.910
Authors: Bin Tu; G Bryan Young; Agnieszka Kokoszka; Andres Rodriguez-Ruiz; Jay Varma; Linda M Eerikäinen; Nadege Assassi; Stephan A Mayer; Jan Claassen; Mika O K Särkelä Journal: Epilepsia Open Date: 2017-01-03
Authors: Ayham Alkhachroum; Brian Appavu; Benjamin Rohaut; Jan Claassen; Satoshi Egawa; Brandon Foreman; Nicolas Gaspard; Emily J Gilmore; Lawrence J Hirsch; Pedro Kurtz; Virginie Lambrecq; Julie Kromm; Paul Vespa; Sahar F Zafar Journal: Intensive Care Med Date: 2022-08-23 Impact factor: 41.787
Authors: Deepika Kurup; Kapil Gururangan; Masoom J Desai; Matthew S Markert; Dawn S Eliashiv; Paul M Vespa; Josef Parvizi Journal: Front Neurol Date: 2022-06-29 Impact factor: 4.086
Authors: Eric S Rosenthal; Jordan J Elm; James Ingles; Alexander J Rogers; Thomas E Terndrup; Maija Holsti; Danny G Thomas; Lynn Babcock; Pamela J Okada; Robert H Lipsky; Joseph B Miller; Robert W Hickey; Megan E Barra; Thomas P Bleck; James C Cloyd; Robert Silbergleit; Daniel H Lowenstein; Lisa D Coles; Jaideep Kapur; Shlomo Shinnar; James M Chamberlain Journal: Neurology Date: 2021-03-23 Impact factor: 9.910
Authors: J L Restrepo-Vera; P Coscojuela; E Fonseca; M Quintana; S Sarria-Estrada; E Santamarina; L Abraira; M Sueiras; V Thonon; J Álvarez-Sabin; M Toledo; A Rovira Journal: J Neurol Date: 2022-02-13 Impact factor: 4.849
Authors: Andrea Biondi; Viviana Santoro; Pedro F Viana; Petroula Laiou; Deb K Pal; Elisa Bruno; Mark P Richardson Journal: Epilepsia Date: 2022-03-27 Impact factor: 6.740